Log In | Register
Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor.
NIH scientists identify possible gene target for treating a form of lymphoma
Seeded on Wed Dec 22, 2010 7:29 PM EST
Article Source: National Institutes of Health- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
Single mutations, or more often, combinations of gene mutations, can lead to the development of cancers such as lymphoma. Lymphoma is a cancer of the blood that arises from infection-fighting white blood cells. Diffuse large B cell lymphoma, a type of non-Hodgkin’s lymphoma, is the most common form of this disease. There are three subtypes of diffuse large B cell lymphoma, of which the activated B cell-like (ABC) form has the poorest three-year survival outcome of 40 percent.
- 1 vote
#1 - Wed Dec 22, 2010 7:30 PM ESTYou're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
